Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



An Open-Label Phase Ib/II Study of Surufatinib in Combination with Tislelizumab in Subjects with Advanced Solid Tumors

Multiple Cancer Types

Miscellaneous, Phase I
I/II
Das, Satya
NCT04579757
VICCPHI20125


A phase 1 study of TJ033721 in subjects with advanced or metastatic solid tumors.

Phase I

Phase I
I
Das, Satya
NCT04900818
VICCPHI2151

Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)

Neuroendocrine

Neuroendocrine
II/III
Das, Satya
NCT05058651
SWOGGIS2012

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: